Boissel Stephane
Insider CIK 1755198 · SGMO EVP, Corporate Strategy
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SGMO SANGAMO THERAPEUTICS, INC | E Expire deriv | 2020-07-03 | 2020-07-31 | 1 | — | $0 | 1 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise deriv | 2020-06-04 | 2020-06-05 | 1 | — | $0 | 2 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise | 2020-06-04 | 2020-06-05 | 14,907 | — | $0 | 85,023 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | D To issuer | 2020-06-04 | 2020-06-05 | 14,907 | $11.23 | $167.4K | 70,116 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | E Expire deriv | 2020-05-09 | 2020-07-31 | 1 | — | $0 | 2 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2020-02-25 | 2020-02-26 | 110,000 | — | $0 | 110,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2020-02-25 | 2020-02-26 | 55,000 | — | $0 | 70,116 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | F Tax w/h | 2020-02-25 | 2020-02-26 | 2,384 | $6.80 | $16.2K | 15,116 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise deriv | 2019-08-12 | 2019-08-14 | 1 | — | $0 | 3 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise | 2019-08-12 | 2019-08-14 | 11,137 | — | $0 | 28,637 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | D To issuer | 2019-08-12 | 2019-08-14 | 11,137 | $11.23 | $125.1K | 17,500 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2019-02-25 | 2019-02-27 | 105,000 | — | $0 | 105,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2019-02-25 | 2019-02-27 | 17,500 | — | $0 | 17,500 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | J Other deriv | 2018-11-27 | 2019-08-14 | 4 | — | $0 | 4 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | J Other deriv | 2018-11-27 | 2019-08-14 | 4 | — | $0 | 4 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2018-11-23 | 2018-11-26 | 283,523 | — | $0 | 283,523 | SEC↗ |